Focal-onset seizures
Clinical trials for Focal-onset seizures explained in plain language.
Never miss a new study
Get alerted when new Focal-onset seizures trials appear
Sign up with your email to follow new studies for Focal-onset seizures, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New epilepsy drug shows promise in final stage trial
Disease control CompletedThis Phase 3 trial tested a drug called XEN1101 (azetukalner) in 380 adults with focal-onset seizures that were not well-controlled by other medications. Participants took either XEN1101 or a placebo alongside their usual seizure drugs. The study measured whether XEN1101 reduced …
Matched conditions: FOCAL-ONSET SEIZURES
Phase 3 • Sponsor: Xenon Pharmaceuticals Inc. • Aim: Disease control
Last updated Jun 27, 2026 12:34 UTC
-
New pill RAP-219 tested for stubborn seizures
Disease control CompletedThis study tested an investigational drug called RAP-219 in 30 adults with refractory focal epilepsy—seizures that don't respond well to current treatments. Participants took RAP-219 tablets to see if it safely reduces seizure frequency. The trial is now complete, and results wil…
Matched conditions: FOCAL-ONSET SEIZURES
Phase 2 • Sponsor: Rapport Therapeutics Inc. • Aim: Disease control
Last updated Jun 27, 2026 09:02 UTC